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Named after Italian mathematician Carlo Emilio Bonferroni (1892–1960) but first attributed to Olive Jean Dunn, the 
Bonferroni correction compensates for multiple comparisons by 
dividing the significance level by the number of comparisons. The 
significance level is the probability that a given test will incorrectly 
find a difference in the sample that is not present in the popula-
tion (false positive). A significance level of 0.05 is a commonly 
accepted significance level. If a study tested 5 comparisons, there 
would be up to a 25% likelihood (0.05 + 0.05 + 0.05 + 0.05 + 
0.05) that any one of them would show a significant difference by 
chance. The Bonferroni correction adjusts for this by dividing the 
significance level by the number of tests. In this case, the signifi-
cance level for a given comparison would be 0.01, for an overall 
risk no larger than 0.05 of falsely detecting a difference.
This technique has been criticized as too conservative, 
particularly when a large number of tests are used, and it may 
increase the risk for a false negative. Other tests, such as the 
Tukey-Kramer and Scheffe method, may reduce this risk.
Bonferroni [bonʹfər-ōʺni] Correction
etymologia
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